For Laboratory Research Use Only · Not for Human or Veterinary Use · 21+
Purest Peptides
Back to Capsules
Made in the USA
NMN (Nicotinamide Mononucleotide) vial

NAD+ Peptide Guide·Capsules

NMN (Nicotinamide Mononucleotide)

Direct NAD+ precursor with 70% sublingual bioavailability.

$44.99/ 30 g powder
View NMN (Nicotinamide Mononucleotide) lab results & testing

For Research Use Only

NMN (Nicotinamide Mononucleotide) is sold strictly for in-vitro laboratory research. Not for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. Not FDA-approved as a therapeutic. Must be 21+ and a qualified researcher to purchase. See our Disclaimer and Research Use Agreement.

Purity
≥ 99.6% HPLC
Format
Capsules
Half-life
9 minutes plasma
Dose
250–1000 mg daily
Mechanism
Direct NAD+ biosynthesis precursor

About NMN (Nicotinamide Mononucleotide)

NMN is a direct precursor to NAD+ that raises whole-blood NAD+ by 38% over 60 days at 1 g daily. Sublingual delivery raises bioavailability to 70% compared with 4% for swallowed capsules.

Reported benefits

  • Raises whole-blood NAD+ by 38% over 60 days
  • 70% sublingual bioavailability
  • Extended median lifespan by 12% in mouse data

Research citations

  • Yoshino et al. 2021 - Science
  • Mills et al. 2016 - Cell Metabolism

How NMN (Nicotinamide Mononucleotide) fits the category

NMN (Nicotinamide Mononucleotide) sits inside the NAD+ Peptide Guide category. For the full ranking and head-to-head comparisons, read NAD+ Peptide Guide.